 |
 | |||
| Want to know the trades that may make you money next week? Here's your playbook to tackle the Street: What's the trade heading into Apple's earnings? Should investors look to battered retail stocks? What's the trade heading into Microsoft's earnings? |  | ||
 | |||
 | Using Volatility - Pete Najarian delves into the world of options. Click here for the Fast Money Trade School Lesson of the week. | ||
 | ||
Is it a buy or a sell? Next week, the Fast Money Five tell you how to read the street’s biggest events so your fast money stays fast Tuesday: Earnings Before: ABK**, BAC**, CSX, DD, FITB, JEC, JNJ**, UNH, WB Earnings After: AAPL**, NSC, TXN Eco: Richmond Fed Wednesday: Earnings Before: ABT, COH, COP, DAL, GD, LUV, MOT**, PFE**, STJ, UTX Earnings After: COF, EBAY, GILD, SOV, SYMC Eco: Mortgage applications Thursday: Earnings Before: DHR, F**, KMB, LEN, LMT, NOK, T**, TXT, XRX Earnings After: AMGN**, BRCM, ETFC, JAVA, JNPR, KLAC, MSFT** Eco: Existing Home Sales Friday: Earnings Before: CAT**, HOG, HON** Earnings After: NONE | ||
 | |||
 | The Fast Money five takes a look at the week's biggest market movers. | ||
 |
 |  |  |
Text to Talk Daily Alerts | Trades you won't find on TV | Fast Money Podcasts Want to go Face 2 Face with the Fast Money Five? Email the fast money team at |
 | |||
 | Just when you thought we had used up all the superlatives for suffering, along comes a 500-point weekly drop in the Dow. And as you search the sea of red on you computer screen, hoping against hope to eke some profit out of all this pain, you might want to familiarize yourself with a term that is quickly gripping the market: counter-party risk. At the heart of the market's sell-off has been the notion that the vast financial engineering that was supposed to protect us from worst-case scenarios might in fact be failing us. But as I say every week in this column, an open market is one in which we can all make money, and with an eye on next week, let's try to do that right now. Earnings season finally kicks into high gear next week. Of particular interest will be Ambac's results on Tuesday. Much of the financial turmoil begins and ends with the bond insurers, and any update they can provide as to their AAA-rating and capital base will go a long way to either unnerving or assuaging the market's anxiety. The rest of earnings season so far has been a pretty mixed bag, with financials like Merrill and Citigroup getting slaughtered by the suprime slime, but other names doing well. GE, the parent company of CNBC, posted some of its best results in years. And tech blue chip IBM also turned in stellar results. Can we expect the same from Tech names like Apple, EBay and Microsoft when they release their respective results on Tuesday, Wednesday and Thursday? The Fast Money will be watching. Also worth watching will be the performance of Big Pharma when Pfizer and Johnson & Johnson report results. Drugs stocks, and to a larger degree healthcare names, will begin to attract more attention as the election heats up. And if the market continues to tank, and rates continue to fall, investors may begin to flock to defensive names with healthy dividends. Keep drug stocks on your Fast Money radar. And keep your head up. Anyone can make money in an up market. It's the tough times that test your trading mettle. I've said it before, and in a market like this, these words could not ring more true: an open market is one in which you can make money. And we will try to just that all next week. I hope you join us.. If you have questions about The Final Trade or suggestions for Fast Money, please send an email to FastMoney@cnbc.com | ||
 |
All opinions expressed by the Program Participants are solely their current opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them. Such opinions are based upon information they consider reliable, but neither CNBC nor its affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. The Program Participants are professional traders who may be actively involved in securities discussed herein, on behalf of themselves, their companies and their clients. Also, the opinions expressed by the Program Participants may be short-term in nature and are subject to change. No part of the Program Participants’ compensation from CNBC is related to the specific opinions they express. Past performance is not indicative of future results. Neither the Program Participants nor CNBC guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed herein. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned herein may not be suitable for you and you should make your own independent decision regarding them. This material does not take into account your particular investment objectives, financial situation or needs and is not intended as recommendations appropriate for you. You should strongly consider seeking advice from your own investment adviser. To unsubscribe from The Final Trade click here |
No comments:
Post a Comment